Showing results (161-170 of 209) with videos related to
Sort By:
Pageof 21
Heart and Vessels|January 28, 2006
The effect of VVI pacing on P-wave dispersion in patients with dual-chamber pacemakersBasri Amasyali, Sedat Köse, Kudret Aytemir, et al.Clinical Cardiology|August 4, 2007
Effect of preload and heart rate on the doppler and tissue doppler-derived myocardial performance indexKurtuluş Ozdemir, Sibel Balci, Mehmet Akif Duzenli, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|July 16, 2011
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapyKenan Demir, Ilknur Can, Fatih Koc, et al.Heart Rhythm|February 24, 2010
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantationImdad Ahmed, Elie Gertner, William B Nelson, et al.The American Journal of Cardiology|July 16, 2005
Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillatorsCengiz Ermis, Alan X Zhu, Laura Vanheel, et al.Heart Rhythm O2|January 2, 2023
Ripple Frequency Determined via a Novel Algorithm Is Associated With Atrial Fibrillation Termination and Freedom From Atrial FibrillationDaniel P Melby, Venkatakrishna N Tholakanahalli, Refael Itah, et al.JACC. Clinical Electrophysiology|May 16, 2018
Post-Extrasystolic Potentiation as a Predictor of Recovery of Left Ventricular Dysfunction After Radiofrequency Catheter AblationBalaji Krishnan, Ashwini Sankar, Inder Anand, et al.Journal of the American College of Cardiology|December 20, 2005
Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillatorsCengiz Ermis, Ryan Seutter, Alan X Zhu, et al.Journal of the American College of Cardiology|November 11, 2008
Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trialTheodore Chow, Dean J Kereiakes, John Onufer, et al.American Heart Journal|March 21, 2016
Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5)Satish R Raj, Peter D Faris, Lisa Semeniuk, et al.Pageof 21